Plasma Kallikrein Inhibitor (Verseon)

N/A

Report date: 2025/01/26 17:38:50
NME

Base Information

Drug NamePlasma Kallikrein Inhibitor (Verseon)
Drug Alias NameKallikrein Inhibitors (Verseon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlasma kallikrein inhibitors
TargetsPlasma kallikrein
Therapy Area/IndicationsDiabetic macular oedemaWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAlbania
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVerseon
China Registration ClassN/A

Develop Information

Active CompaniesVerseon
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A